Plain-English translation of NCT06662500 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Shockwave Javelin Coronary IVL Catheter, a new device that uses shock waves to break up calcium deposits in severely narrowed heart arteries. The goal is to soften the hardened, calcified blockages so that doctors can more easily open them up and restore blood flow to the heart. This treatment is designed for people with stable chest pain or those who have recovered from a heart attack and have tight, calcified blockages that are difficult to treat with standard methods.
Calcium buildup in heart arteries is one of the hardest types of blockage for doctors to treat, and standard balloon and stent procedures don't always work well. This trial is exploring whether using sound wave technology to soften the calcium first will make treatment safer and more successful for patients with these stubborn blockages.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo a cardiac catheterization procedure where doctors will use the new shock wave device to treat your calcified heart artery blockage. The procedure itself is similar to standard heart catheterization—a small tube is threaded to your heart through a blood vessel, and the device delivers controlled shock waves to soften the calcium. After the procedure, you will need to attend follow-up visits so doctors can monitor your recovery and check how well the treatment worked.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
United States